STERIS plc (NYSE:STE) Shares Acquired by Wellington Management Group LLP

Wellington Management Group LLP lifted its holdings in STERIS plc (NYSE:STE - Free Report) by 4,534.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 219,032 shares of the medical equipment provider's stock after acquiring an additional 214,306 shares during the period. Wellington Management Group LLP owned 0.22% of STERIS worth $45,024,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in STE. Select Equity Group L.P. boosted its holdings in shares of STERIS by 165.3% in the 4th quarter. Select Equity Group L.P. now owns 2,599,730 shares of the medical equipment provider's stock worth $534,400,000 after purchasing an additional 1,619,796 shares during the period. Geode Capital Management LLC increased its position in STERIS by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 2,359,748 shares of the medical equipment provider's stock valued at $483,775,000 after acquiring an additional 56,123 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of STERIS by 15.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,261,927 shares of the medical equipment provider's stock valued at $257,585,000 after acquiring an additional 172,795 shares during the period. Franklin Resources Inc. lifted its holdings in shares of STERIS by 45.1% in the 4th quarter. Franklin Resources Inc. now owns 1,216,821 shares of the medical equipment provider's stock worth $250,130,000 after acquiring an additional 378,252 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in shares of STERIS by 7.4% during the 4th quarter. Northern Trust Corp now owns 1,213,037 shares of the medical equipment provider's stock worth $249,352,000 after purchasing an additional 83,601 shares during the period. Hedge funds and other institutional investors own 94.69% of the company's stock.

STERIS Stock Down 1.1%

NYSE:STE traded down $2.71 during mid-day trading on Monday, reaching $242.50. The company's stock had a trading volume of 205,668 shares, compared to its average volume of 543,674. STERIS plc has a 1 year low of $200.98 and a 1 year high of $252.79. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $23.83 billion, a PE ratio of 51.51 and a beta of 0.96. The stock has a fifty day moving average of $228.42 and a 200-day moving average of $220.91.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share for the quarter, topping analysts' consensus estimates of $2.59 by $0.15. STERIS had a return on equity of 13.91% and a net margin of 8.66%. The firm had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.47 billion. During the same period in the prior year, the business posted $2.58 EPS. The firm's quarterly revenue was up 5.7% on a year-over-year basis. Equities research analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 0.94%. The ex-dividend date of this dividend is Tuesday, June 10th. STERIS's dividend payout ratio is currently 36.77%.

Insiders Place Their Bets

In related news, SVP Cary L. Majors sold 12,828 shares of the business's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $250.08, for a total value of $3,208,026.24. Following the sale, the senior vice president now directly owns 11,372 shares in the company, valued at approximately $2,843,909.76. The trade was a 53.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.14% of the company's stock.

Analysts Set New Price Targets

STE has been the topic of a number of recent analyst reports. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Piper Sandler increased their price target on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Stephens reissued an "overweight" rating and set a $250.00 price target on shares of STERIS in a research note on Thursday, May 15th. Citigroup reiterated an "outperform" rating on shares of STERIS in a research note on Friday, May 16th. Finally, Jefferies Financial Group initiated coverage on shares of STERIS in a report on Thursday. They issued a "hold" rating and a $263.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $263.83.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.